Iovance Biotherapeutics Inc. Common Stock vs NXP Semiconductors N.V. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B), while NXP Semiconductors N.V. Common Stock trades at $227.52 (market cap $58.27B). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 9.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and NXP Semiconductors N.V. Common Stock for 0 Days on average.
| IOVA | NXPI | |
|---|---|---|
Market Cap | $6.04B | $58.27B |
Volume | 14,805,993 | 3,950,702 |
Sector | Health | Technology |
52-Week High | $14.82 | $332.67 |
52-Week Low | $1.81 | $184.19 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $66.38B |
Dividend Yield | — | 1.76% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →